(NTR) Nutrien - Ratings and Ratios
Exchange: NYSE • Country: Canada • Currency: USD • Type: Common Stock • ISIN: CA67077M1086
NTR: Crop Nutrients, Seeds, Fertilizers, Potash, Nitrogen, Phosphate
Nutrien Ltd. is a global leader in the agriculture sector, specializing in crop inputs and services. The company is structured into four core segments: Retail, Potash, Nitrogen, and Phosphate. Its Retail segment is a cornerstone of the business, offering a wide range of products including crop nutrients, seeds, crop protection chemicals, and merchandise. This segment also operates an extensive network of farm centers across North America, South America, and Australia, providing direct support to growers.
The Potash segment is a critical part of Nutriens operations, producing both granular and standard potash products. Potash is a vital nutrient for plant growth, and Nutriens position as one of the worlds largest potash producers gives it significant influence in the global fertilizer market. The Nitrogen segment adds another layer of diversification, offering products like ammonia, urea, and environmentally smart nitrogen solutions. This segment also produces nitrates and sulfates, catering to the growing demand for sustainable nitrogen-based fertilizers.
The Phosphate segment rounds out Nutriens fertilizer portfolio, providing solid and liquid fertilizers, as well as industrial and feed products. Phosphate is essential for plant DNA development and energy transfer, making it a cornerstone of modern agriculture. Together, these segments position Nutrien as a one-stop-shop for growers worldwide, offering a comprehensive suite of products and services tailored to meet the needs of modern farming.
Headquartered in Saskatoon, Canada, Nutrien operates on a global scale, with a market capitalization of over $25 billion USD. The company currently trades with a P/E ratio of 34.16 and a forward P/E of 13.99, indicating expectations of future growth. Its price-to-book ratio of 1.00 and price-to-sales ratio of 0.98 suggest a balanced valuation relative to its financial fundamentals. For investors and fund managers looking to gain exposure to the agriculture and fertilizer sectors, Nutriens diversified operations and global reach make it a key player worth considering.
Additional Sources for NTR Stock
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
NTR Stock Overview
Market Cap in USD | 25,162m |
Sector | Basic Materials |
Industry | Agricultural Inputs |
GiC Sub-Industry | Fertilizers & Agricultural Chemicals |
IPO / Inception | 2018-01-02 |
NTR Stock Ratings
Growth 5y | 30.7% |
Fundamental | 2.54% |
Dividend | 78.8% |
Rel. Strength Industry | 3.66 |
Analysts | 3.88/5 |
Fair Price Momentum | 50.74 USD |
Fair Price DCF | 162.47 USD |
NTR Dividends
Dividend Yield 12m | 5.40% |
Yield on Cost 5y | 11.80% |
Annual Growth 5y | 3.71% |
Payout Consistency | 100.0% |
NTR Growth Ratios
Growth Correlation 3m | 54.4% |
Growth Correlation 12m | -28.4% |
Growth Correlation 5y | 19.8% |
CAGR 5y | 17.22% |
CAGR/Max DD 5y | 0.30 |
Sharpe Ratio 12m | -1.32 |
Alpha | -7.13 |
Beta | 0.45 |
Volatility | 31.59% |
Current Volume | 1671k |
Average Volume 20d | 2716.8k |
As of March 16, 2025, the stock is trading at USD 50.79 with a total of 1,671,011 shares traded.
Over the past week, the price has changed by -0.57%, over one month by -0.22%, over three months by +9.66% and over the past year by -0.02%.
Neither. Based on ValueRay Fundamental Analyses, Nutrien is currently (March 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 2.54 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of NTR as of March 2025 is 50.74. This means that NTR is currently overvalued and has a potential downside of -0.1%.
Nutrien has received a consensus analysts rating of 3.88. Therefor, it is recommend to buy NTR.
- Strong Buy: 10
- Buy: 6
- Hold: 6
- Sell: 2
- Strong Sell: 1
According to ValueRays Forecast Model, NTR Nutrien will be worth about 54.8 in March 2026. The stock is currently trading at 50.79. This means that the stock has a potential upside of +7.9%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 60.9 | 19.8% |
Analysts Target Price | 58.4 | 14.9% |
ValueRay Target Price | 54.8 | 7.9% |